Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “anti-”

1,068 pharma patents match "anti-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,068
Index total 30,257
Page 11 / 45

Quick answer

This filtered view shows 1,068 pharmaceutical patents matching "anti-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,068 results for “anti-” · 30,257 patents in full index Clear search

  1. US 11753466

    Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  2. US 11753459

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  3. CA 3245150

    COMBINAISONS AVEC UN ANTICORPS ANTI-CD39 HUMAIN, UN ANTICORPS ANTI-PD-1 HUMAIN ET UNE CHIMIOTHÉRAPIE CONTRE LE CANCER GASTRIQUE

    TRISHULA THERAPEUTICS INC [US] · Granted Sep 7, 2023 · Expires Sep 2, 2043

    granted
  4. US 11744926

    Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications

    The Board of Regents of the University of Texas System · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted
  5. US 11732025

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  6. US 11732030

    Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  7. US 11725054

    Anti-CD83 antibodies and use thereof

    The Regents of the University of California · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  8. US 11723864

    Antimicrobial and anti-inflammatory compositions

    The Board of Regents of the University of Texas System · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  9. US 11708413

    Anti-CD74 antibody conjugates, compositions comprising anti-CD74 antibody conjugates and methods of using anti-CD74 antibody conjugates

    Sutro Biopharma, Inc. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  10. US 11708352

    Anti-cancer compounds

    The Regents of the University of California · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  11. US 11708406

    Method of treating acute respiratory distress syndrome (ARDS) or acute lung injury (ALI) associate with COVID-19 by administering an anti-LIGHT antibody

    AVALO THERAPEUTICS, INC. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  12. US 11697676

    Anti-human papillomavirus 16 E6 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 11, 2023 · Expires Jul 6, 2043

    granted
  13. US 11690918

    Pyrrolobenzodiazepine-anti-CD22 antibody conjugates

    ADC THERAPEUTICS SA · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted
  14. US 11692032

    Anti-LAG3 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted
  15. US 2023203129

    ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES

    BRACCO IMAGING SPA [IT] · Granted Jun 29, 2023 · Expires Jun 24, 2043

    granted
  16. US 11685784

    Anti-immune-checkpoint nanobody and nucleic acid encoding sequence thereof, and uses of the same

    China Medical University Hospital · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  17. US 11673967

    Stabilized formulations containing anti-PCSK9 antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  18. US 11672872

    Anti-transferrin receptor antibody and uses thereof

    Dyne Therapeutics, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  19. US 11672785

    Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs

    Olema Pharmaceuticals, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  20. US 2023174645

    ANTI-HEMOJUVELIN (HJV) ANTIBODIES FOR TREATING MYELOFIBROSIS

    DISC MEDICINE INC [US] · Granted Jun 8, 2023 · Expires Jun 3, 2043

    granted
  21. US 11667701

    Anti-PfRH5 antibodies and antigen-binding fragments thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  22. US 11655286

    Anti-PcrV antibodies that bind PcrV, compositions comprising anti-PcrV antibodies, and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  23. US 11654187

    Horn fly protein as active antigen in anti-horn fly vaccine for protection of bovines against horn fly infestations

    The United States of America, as represented by the Secretary of Agriculture · Granted May 23, 2023 · Expires May 18, 2043

    granted
  24. US 11655307

    Anti-doublecortin-like kinase 1 antibodies and methods of use

    The Board of Regents of the University of Oklahoma · Granted May 23, 2023 · Expires May 18, 2043

    granted